NOV 15, 2018 10:30 AM PST

Management of HPV-Positive Women by QIAsure Methylation Test

Sponsored by: QIAGEN
Speaker
  • CEO Self-Screen, Emeritus Professor of Pathology, VUmc
    Biography
      hris Meijer MD, PhD, has been a surgical pathologist since 1977. He performs translational research in the field of oncology with emphasis on HPV and HPV-associated cancers. He was chairman of the Department of Pathology, VU-UMC Amsterdam from 1983-2010 and has been awarded for his research on numerous occasions by (Inter)national organizations.
      Presently, he leads a research group focusing on the development of a full molecular cervical cancer self-screening algorithm and is a part-time director of Self-Screen bv, a company that develops diagnostic molecular tests for cervical (pre)cancer.

    Abstract

    Cervical cancer is the 4th most common cancer worldwide with 528,000 new cases and 266,000 deaths every year. It is also the only cancer 100% preventable. It has been extensively proved, that cervical cancer is caused by persistent infections with the human papilloma virus, termed high-risk HPV. In these persistent infections, there is a characteristic cumulative process called hypermethylation, which can eventually silence some critical tumour suppressor genes of the host cells.

    Only around 20% of CIN2/3 lesions will progress to cancer, but still the majority of these are overtreated by ablative therapy leading to comorbidity, especially for women in their child bearing years. 

    Hypermethylation of FAM 19A4 and miR124-2 have been shown to be reliable markers of disease progression, and can be used to determine if a CIN2/3 lesion is transforming into carcinoma.

    QIAGEN´s QIAsure Methylation Test identifies cervical cancer and the preceding CIN lesion with high short-term progression risk. It has been validated in six different European screening settings as a triage test applicable for both HPV and/or cytology screened populations. It brings valuable benefits for the physician, the patient and has proven to improve cost effectiveness for health care organizations and insurance companies.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    NOV 15, 2018 10:30 AM PST

    Management of HPV-Positive Women by QIAsure Methylation Test

    Sponsored by: QIAGEN

    Specialty

    Health

    Cancer

    Disease

    Therapy

    Molecular Diagnostics

    Laboratory Testing

    Diagnostics

    Clinical Diagnostics

    Biomarkers

    Hepatitis

    Veterinary Sciences

    Biology

    Molecular Biology

    Infectious Disease

    Gonorrhea

    Geography

    North America60%

    Asia20%

    Europe20%

    Registration Source

    Website Visitors100%

    Job Title

    Facility/Department Manager50%

    Medical Laboratory Technician50%

    Organization

    Manufacturer - Other40%

    Animal Hospital20%

    Hospital20%

    Clinical Laboratory20%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more